Bo Ge

688 total citations
26 papers, 538 citations indexed

About

Bo Ge is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Bo Ge has authored 26 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Bo Ge's work include Peptidase Inhibition and Analysis (5 papers), MicroRNA in disease regulation (4 papers) and Neuropeptides and Animal Physiology (4 papers). Bo Ge is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), MicroRNA in disease regulation (4 papers) and Neuropeptides and Animal Physiology (4 papers). Bo Ge collaborates with scholars based in China, South Sudan and Germany. Bo Ge's co-authors include Li Zhou, Lu Wang, Lin Shi, Li Gao, Wei Yi, Ye Yu, Xing Zhang, Jian Chen, Jun Chen and Tianpeng Zheng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Psychosomatic Medicine and Medicine.

In The Last Decade

Bo Ge

23 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Ge China 13 209 84 84 82 67 26 538
Meifang Wang China 13 228 1.1× 70 0.8× 74 0.9× 122 1.5× 45 0.7× 40 593
Mohammad Rahmati Iran 16 379 1.8× 62 0.7× 91 1.1× 63 0.8× 51 0.8× 51 774
Yuqian Cui China 16 225 1.1× 87 1.0× 85 1.0× 48 0.6× 30 0.4× 31 731
Yuhan Jiang China 15 235 1.1× 55 0.7× 57 0.7× 50 0.6× 26 0.4× 72 624
Mao Luo China 13 212 1.0× 103 1.2× 83 1.0× 62 0.8× 19 0.3× 19 667
Xiaotian Li China 18 353 1.7× 46 0.5× 81 1.0× 85 1.0× 32 0.5× 46 835
Mahmood Khaksary Mahabady Iran 13 335 1.6× 86 1.0× 168 2.0× 65 0.8× 49 0.7× 37 680
Qiujing Li China 11 198 0.9× 165 2.0× 62 0.7× 98 1.2× 41 0.6× 18 686
Conghui Liu China 10 339 1.6× 126 1.5× 56 0.7× 187 2.3× 35 0.5× 15 788
Sourabh Soni United States 12 245 1.2× 175 2.1× 162 1.9× 84 1.0× 26 0.4× 24 758

Countries citing papers authored by Bo Ge

Since Specialization
Citations

This map shows the geographic impact of Bo Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Ge more than expected).

Fields of papers citing papers by Bo Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Ge. The network helps show where Bo Ge may publish in the future.

Co-authorship network of co-authors of Bo Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Ge. A scholar is included among the top collaborators of Bo Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Ge. Bo Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Xiaohui, Li Gao, Jiawei Zhao, et al.. (2025). Association between ESRα and ESRβ polymorphisms and prostate cancer risk: meta-analysis. Frontiers in Oncology. 15. 1630363–1630363.
2.
Zhang, Jianbo, et al.. (2024). Construction of a self-floating fabric based on CVD-assisted coating and its application in interfacial evaporation. Progress in Organic Coatings. 199. 108959–108959. 2 indexed citations
3.
Liang, Bojian, et al.. (2023). Anti-bladder cancer and COVID-19 potentials of pachymic acid: clinical features and therapeutic targets. International Journal of Food Properties. 26(1). 2679–2691. 1 indexed citations
4.
Wei, Wei, et al.. (2022). Effects of female obesity on conception, pregnancy and the health of offspring. Frontiers in Endocrinology. 13. 949228–949228. 18 indexed citations
5.
Zhang, Jiajie, et al.. (2022). Effect of percutaneous nephrolithotripsy under guidance of B-ultrasound for the treatment of complex renal calculi. SHILAP Revista de lepidopterología. 72(6). 1198–1200. 3 indexed citations
7.
Gao, Li, Sen Zhang, Yun Zhou, et al.. (2020). Zinc Ion-Stabilized Aptamer-Targeted Black Phosphorus Nanosheets for Enhanced Photothermal/Chemotherapy Against Prostate Cancer. Frontiers in Bioengineering and Biotechnology. 8. 769–769. 23 indexed citations
9.
Tang, Rongyu, et al.. (2020). Poor bladder compliance due to malacoplakia with xanthogranulomatous cystitis. Medicine. 99(26). e20852–e20852. 2 indexed citations
10.
Ge, Bo, Xu Chen, Bo Chen, et al.. (2019). The Relationship Between Plasma DPP4 Activity to BDNF Ratio and Mild Cognitive Impairment in Elderly Population With Normal Glucose Tolerance. Frontiers in Aging Neuroscience. 11. 33–33. 10 indexed citations
11.
Ge, Bo, Chao Guo, Yujia Liang, Meizhen Liu, & Ka Wu. (2019). Network analysis, and human and animal studies disclose the anticystitis glandularis effects of vitamin C. BioFactors. 45(6). 912–919. 19 indexed citations
12.
Song, Jianfei, Xiaoxi Zhang, Xueping Hu, et al.. (2018). Association of Serum Angiopoietin-Like Protein 8 With Albuminuria in Type 2 Diabetic Patients: Results From the GDMD Study in China. Frontiers in Endocrinology. 9. 414–414. 13 indexed citations
13.
Zheng, Tianpeng, Bo Ge, Hongbo Liu, et al.. (2018). Triglyceride-mediated influence of serum angiopoietin-like protein 8 on subclinical atherosclerosis in type 2 diabetic patients: results from the GDMD study in China. Cardiovascular Diabetology. 17(1). 84–84. 27 indexed citations
14.
Chen, Yi, Ya Peng, Zhipeng Xu, et al.. (2018). Knockdown of lncRNA SNHG7 inhibited cell proliferation and migration in bladder cancer through activating Wnt/β-catenin pathway. Pathology - Research and Practice. 215(2). 302–307. 31 indexed citations
15.
Zhou, Li, Li Gao, Tianyu Zhang, et al.. (2018). Anti-proliferative benefit of curcumol on human bladder cancer cells via inactivating EZH2 effector. Biomedicine & Pharmacotherapy. 104. 798–805. 27 indexed citations
16.
Ge, Bo, Daping Yang, Xinmou Wu, et al.. (2017). Cytoprotective effects of glycyrrhetinic acid liposome against cyclophosphamide-induced cystitis through inhibiting inflammatory stress. International Immunopharmacology. 54. 139–144. 28 indexed citations
17.
Liao, Ran, et al.. (2015). Effects of siRNA Livin on EJ human bladder cancer cells treated with mitomycin-C. Oncology Letters. 10(4). 2422–2426. 1 indexed citations
18.
Chen, Jian, et al.. (2015). Biochanin A Promotes Proliferation that Involves a Feedback Loop of MicroRNA-375 and Estrogen Receptor Alpha in Breast Cancer Cells. Cellular Physiology and Biochemistry. 35(2). 639–646. 44 indexed citations
19.
Chen, Jun, et al.. (2015). Genistein induces apoptosis by the inactivation of the IGF-1R/p-Akt signaling pathway in MCF-7 human breast cancer cells. Food & Function. 6(3). 995–1000. 83 indexed citations
20.
Zeng, Hao, Xiaojie Wang, Ying Huang, et al.. (2008). Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland. Experimental Eye Research. 88(1). 4–11. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026